Stay updated with breaking news from Accula System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CHICAGO, May 1, 2023 /PRNewswire/ -- The multiplex assays industry is expected to experience significant growth in the near future. This is due to the increasing demand for multiplex assays
Industry News: Thermo Fisher Scientific to acquire point-of-care molecular diagnostics provider Mesa Biotech The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases 22 Jan 2021 Thermo Fisher Scientific Inc., a world leader in serving science, has announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million...
Thermo Fisher To Buy Molecular Diagnostics Company Mesa Biotech For About $450 Mln WASHINGTON (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO) said Tuesday it has agreed to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for about $450 million in cash. Under the terms of the deal, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction. Thermo Fisher expects the transaction to be completed in the first quarter of 2021. Upon completion, the business will become part of Thermo Fis...
Thermo Fisher to Buy Mesa Biotech for $450 Million Thermo will take over a company that has developed a rapid Covid test. The deal is expected to close this quarter. Author: Shares of Thermo Fisher Scientific ( TMO) - Get Report rose Tuesday after the medical/scientific equipment giant announced it’s buying Mesa Biotech, a privately-held molecular diagnostic company, for $450 million in cash. Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction. Thermo expects the deal to close this quarter. Ther...
Thermo Fisher Scientific Inc. the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the ...